Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Induction of Neurotrophic Factors GDNF and BDNF Associated with the Mechanism of Neurorescue Action of Rasagiline and Ladostigil

Identifieur interne : 000497 ( Main/Curation ); précédent : 000496; suivant : 000498

Induction of Neurotrophic Factors GDNF and BDNF Associated with the Mechanism of Neurorescue Action of Rasagiline and Ladostigil

Auteurs : Orly Weinreb [Israël] ; Tamar Amit [Israël] ; Orit Bar-Am [Israël] ; Moussa B. H. Youdim [Israël]

Source :

RBID : ISTEX:5EAC9668293D9862FCDE564B5D7CA0CE912F292C

English descriptors

Abstract

Abstract:  Parkinson's disease (PD) and Alzheimer's disease (AD) are the most common neurodegenerative disorders, although there is no drug or therapeutic treatment to demonstrate disease‐modifying effects. Previous work has proposed that neurodegeneration is linked to a lack of trophic support in those neurons and brain areas associated with PD and AD. Indeed, previous studies have found that neurotrophic factors (NTFs) support neuronal survival in various cellular and animal models of PD and AD. Thus, attention has begun to turn to the possibility of NTF neuroprotective–neurorescue therapies for these diseases, indicating that NTFs may be of significant clinical importance as exogenously supplied or endogenously induced elements that obliterate neuronal deficits and degeneration. We have recently reported that the anti‐PD drug rasagiline, the anti‐AD drug ladostigil, and their propargyl moiety, propargylamine, enhanced the expression levels of brain‐derived neurotrophic factor and glial cell line–derived neurotrophic factor, endogenous NTFs associated with activation of phosphatidylinositol 3‐kinase, protein kinase, and mitogen‐activated protein kinase cell signaling/survival pathways. These studies indicate that the induction of NTFs by rasagiline and ladostigil might suppress apoptosis and induce neurorescue in neurodegenerative disorders and may support the drugs' possible disease‐modifying mechanism of action.

Url:
DOI: 10.1196/annals.1403.011

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:5EAC9668293D9862FCDE564B5D7CA0CE912F292C

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Induction of Neurotrophic Factors GDNF and BDNF Associated with the Mechanism of Neurorescue Action of Rasagiline and Ladostigil</title>
<author>
<name sortKey="Weinreb, Orly" sort="Weinreb, Orly" uniqKey="Weinreb O" first="Orly" last="Weinreb">Orly Weinreb</name>
<affiliation wicri:level="1">
<mods:affiliation>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa, Israel</mods:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Amit, Tamar" sort="Amit, Tamar" uniqKey="Amit T" first="Tamar" last="Amit">Tamar Amit</name>
<affiliation wicri:level="1">
<mods:affiliation>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa, Israel</mods:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bar M, Orit" sort="Bar M, Orit" uniqKey="Bar M O" first="Orit" last="Bar-Am">Orit Bar-Am</name>
<affiliation wicri:level="1">
<mods:affiliation>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa, Israel</mods:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Youdim, Moussa B H" sort="Youdim, Moussa B H" uniqKey="Youdim M" first="Moussa B. H." last="Youdim">Moussa B. H. Youdim</name>
<affiliation wicri:level="1">
<mods:affiliation>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa, Israel</mods:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5EAC9668293D9862FCDE564B5D7CA0CE912F292C</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1196/annals.1403.011</idno>
<idno type="url">https://api.istex.fr/document/5EAC9668293D9862FCDE564B5D7CA0CE912F292C/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000572</idno>
<idno type="wicri:Area/Main/Curation">000497</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Induction of Neurotrophic Factors GDNF and BDNF Associated with the Mechanism of Neurorescue Action of Rasagiline and Ladostigil</title>
<author>
<name sortKey="Weinreb, Orly" sort="Weinreb, Orly" uniqKey="Weinreb O" first="Orly" last="Weinreb">Orly Weinreb</name>
<affiliation wicri:level="1">
<mods:affiliation>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa, Israel</mods:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Amit, Tamar" sort="Amit, Tamar" uniqKey="Amit T" first="Tamar" last="Amit">Tamar Amit</name>
<affiliation wicri:level="1">
<mods:affiliation>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa, Israel</mods:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bar M, Orit" sort="Bar M, Orit" uniqKey="Bar M O" first="Orit" last="Bar-Am">Orit Bar-Am</name>
<affiliation wicri:level="1">
<mods:affiliation>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa, Israel</mods:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Youdim, Moussa B H" sort="Youdim, Moussa B H" uniqKey="Youdim M" first="Moussa B. H." last="Youdim">Moussa B. H. Youdim</name>
<affiliation wicri:level="1">
<mods:affiliation>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa, Israel</mods:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Eve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases Research and Department of Pharmacology, Rappaport Family Research Institute, Technion‐Faculty of Medicine, Haifa</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Annals of the New York Academy of SciencesNeuroprotective Agents: Eighth International Neuroprotection Society Meeting</title>
<idno type="ISSN">0077-8923</idno>
<idno type="eISSN">1749-6632</idno>
<imprint>
<publisher>Blackwell Publishing Inc</publisher>
<pubPlace>Malden, USA</pubPlace>
<date type="published" when="2007-12">2007-12</date>
<biblScope unit="volume">1122</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="155">155</biblScope>
<biblScope unit="page" to="168">168</biblScope>
</imprint>
<idno type="ISSN">0077-8923</idno>
</series>
<idno type="istex">5EAC9668293D9862FCDE564B5D7CA0CE912F292C</idno>
<idno type="DOI">10.1196/annals.1403.011</idno>
<idno type="ArticleID">NYAS1122011</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0077-8923</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Alzheimer's disease</term>
<term>BDNF</term>
<term>GDNF</term>
<term>Parkinson's disease</term>
<term>neuroprotection/neurorescue</term>
<term>neurorestoration</term>
<term>neurotrophic factors</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract:  Parkinson's disease (PD) and Alzheimer's disease (AD) are the most common neurodegenerative disorders, although there is no drug or therapeutic treatment to demonstrate disease‐modifying effects. Previous work has proposed that neurodegeneration is linked to a lack of trophic support in those neurons and brain areas associated with PD and AD. Indeed, previous studies have found that neurotrophic factors (NTFs) support neuronal survival in various cellular and animal models of PD and AD. Thus, attention has begun to turn to the possibility of NTF neuroprotective–neurorescue therapies for these diseases, indicating that NTFs may be of significant clinical importance as exogenously supplied or endogenously induced elements that obliterate neuronal deficits and degeneration. We have recently reported that the anti‐PD drug rasagiline, the anti‐AD drug ladostigil, and their propargyl moiety, propargylamine, enhanced the expression levels of brain‐derived neurotrophic factor and glial cell line–derived neurotrophic factor, endogenous NTFs associated with activation of phosphatidylinositol 3‐kinase, protein kinase, and mitogen‐activated protein kinase cell signaling/survival pathways. These studies indicate that the induction of NTFs by rasagiline and ladostigil might suppress apoptosis and induce neurorescue in neurodegenerative disorders and may support the drugs' possible disease‐modifying mechanism of action.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000497 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000497 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:5EAC9668293D9862FCDE564B5D7CA0CE912F292C
   |texte=   Induction of Neurotrophic Factors GDNF and BDNF Associated with the Mechanism of Neurorescue Action of Rasagiline and Ladostigil
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024